ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 1278

$722K Total Retail Price of All Prescriptions

Rank: 44 out of 1278

761 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 761 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 761 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 7,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
HYDROCODONE-ACETAMINOPHEN 536 314 S3 1 7
LISINOPRIL 463 412 2 1
LEVOTHYROXINE SODIUM 444 372 3 2
SIMVASTATIN 378 349 4 3
METFORMIN HCL 245 191 5 4
ZOLPIDEM TARTRATE 231 170 6 16
CARISOPRODOL 221 99 R 7 51
HYDROCHLOROTHIAZIDE 183 157 8 8
CRESTOR 167 154 9 31
GABAPENTIN 156 64 10 12
OMEPRAZOLE 151 133 11 6
METOPROLOL TARTRATE 133 128 12 9
LOSARTAN POTASSIUM 131 125 13 19
ATENOLOL 129 113 14 11
WARFARIN SODIUM 129 101 14 17
ATORVASTATIN CALCIUM 122 110 16 15
MORPHINE SULFATE ER 119 29 S2 17 42
OXYCODONE HCL 117 38 S2 18 27
FUROSEMIDE 117 96 18 10
CITALOPRAM HBR 92 50 20 22
OXYCODONE-ACETAMINOPHEN 86 46 S2 21 29
AMLODIPINE BESYLATE 85 84 22 5
PEN NEEDLE 84 77 23 154
ALLOPURINOL 81 70 24 36
OXYCONTIN 81 41 S2 24 89
ALENDRONATE SODIUM 78 73 26 18
TERAZOSIN HCL 77 76 27 59
TRAMADOL HCL 77 71 27 25
PANTOPRAZOLE SODIUM 75 60 29 34
LOVASTATIN 71 65 30 13
PROPRANOLOL HCL 71 54 30 145
VYTORIN 70 64 32 85
TAMSULOSIN HCL 69 64 33 32
FENTANYL 69 17 S2 33 97
ESCITALOPRAM OXALATE 68 47 35 134
IBUPROFEN 66 60 36 46
CARVEDILOL 64 57 37 39
TRIAMTERENE-HCTZ 63 57 38 43
BENAZEPRIL HCL 62 62 39 81
RANITIDINE HCL 59 57 40 20
ESTRADIOL 58 46 R 41 71
INSULIN SYRINGE 56 49 42 50
POTASSIUM CHLORIDE 55 45 43 21
OXYCODONE HCL-ACETAMINOPHEN 55 33 S2 43 76
LEVOXYL 55 55 43 94
TEMAZEPAM 52 41 46 345
PROAIR HFA 50 30 47 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.